By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children
Overview
These guidelines address the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children, including new guidance on the management of resistant hypertension and the management of hypertension in women planning pregnancy.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: May 1, 2020
Contact: practice@apta.org
Content Type: CPG
Preschool Child (2-5), Young Adult (19-24), Middle Aged (45-64), Child (6-12), Aged (65+), Adult (25-44), Adolescent (13-18), 80 and over (80+)
Rabi DM, McBrien KA, Sapir-Pichhadze R, et al
You Might Also Like...
CPG
ESC/ERS 2022 Guidelines for the Diagnosis and Treatment of Pulmonary HypertensionOct 7, 2022
Focuses on how pulmonary hypertension (PH) may involve multiple clinical conditions and pose complications for the majority of cardiovascular and respiratory
CPG
Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and ManagementMay 1, 2022
These updated guidelines from the Society of Obstetricians and Gynaecologists of Canada present the current evidence to provide a reasonable approach to
CPG
Hypertension in Adults: Diagnosis and Management [NICE NG136]Aug 28, 2019
Covers identifying and treating primary hypertension in people aged 18 and over, including people with type 2 diabetes.